More Biomarkers Needed in Cancer Immunotherapy More Biomarkers Needed in Cancer Immunotherapy

PD-L1 has proven to be a helpful but limited biomarker in helping clinicians choose cancer patients for immune checkpoint inhibition.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news